ÀÏ°³ °ËÁø¼¾ÅÍ¿¡¼ °íÁöÇ÷ÁõÀ¸·Î Áø´ÜµÈ ȯÀÚµéÀÇ º¹¾à¼øÀÀµµ ¹× °ü·Ã ¿äÀÎ
Compliance of Hyperlipidemia Medication and Related Factors in a Health Screening Center
Korean Journal of Family Practice 2014³â 4±Ç 2È£ p.164 ~ p.170
¹è¸®¾Æ(Bae Ri-Ah) - ´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ °¡Á¤ÀÇÇб³½Ç
Á¤À¯¼®(Cheong Yoo-Seock) - ´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ °¡Á¤ÀÇÇб³½Ç
¹ÚÀÏȯ(Park Eal-Whan) - ´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ °¡Á¤ÀÇÇб³½Ç
ÃÖÀº¿µ(Choi Eun-Young) - ´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ °¡Á¤ÀÇÇб³½Ç
¼»ó¿í(Seo Sang-Wook) - ´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ °¡Á¤ÀÇÇб³½Ç
Abstract
Background: Hyperlipidemia is well known risk factor for coronary heart disease. Persistence with lipid-lowering drug therapy in Korea has not been studied much previously. This study was designed to determine the rate at which patients with hyperlipidemia persist in taking lipid-lowering agents, and to analyze related factors in a health screening center.
Methods: This was a retrospective study that utilized data from the heath screening center in a university hospital to analyze persistence rates with statins. The study included data for 150 patients who started lipid-lowering therapy between January 2011, and February 2012. Main outcome measures included the percentage of patients persisting in therapy for the fi rst 4 weeks and mean of medication days.
Results: The percentage of patients who persisted with overall statin therapy was 52% after 1 month. Persistence was better in elderly patients, non-smokers, regular exercisers, and patients with good knowledge of hyperlipidemia. The main reason for discontinuation is burden of life-long medication (48.6%).
Conclusion: Persistence with statin therapy by patients in a Korean health screening center was low compared with other clinical settings. Low persistence may have negated potential clinical benefi ts of long-term statin therapy.
Å°¿öµå
Hyperlipidemias, Lipid Lowering Drug, Compliance
KMID :
1039620140040020164
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
Persistence of the lipid-lowing therapy with statin was better in elderly patients, non-smokers, regular exercisers, and patients with good knowledge of hyperlipidemia.